ストックスクリーナーアプリを入手
17.50
1.82%
-0.64
前日終値:
$18.14
開ける：
$18.1
24時間の取引高:
9,153
Relative Volume:
1.72
時価総額：
$423.55M
収益：
$4.66M
当期純損益:
$-110.22M
株価収益率:
-3.8349
EPS:
-4.5634
ネットキャッシュフロー:
$-84.82M
1週間 パフォーマンス:
+2.65%
1か月 パフォーマンス:
+14.75%
6か月 パフォーマンス:
+4.15%
1年 パフォーマンス:
+1.48%
1日の値動き範囲:
$17.12
$18.10
1週間の範囲:
$17.12
$19.33
52週間の値動き範囲:
$14.50
$19.92
Puretech Health Plc Adr Stock (PRTC) Company Profile
Compare PRTC vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
17.40 | 441.56M | 4.66M | -110.22M | -84.82M | -4.5634 |
VRTX
Vertex Pharmaceuticals Inc
|
427.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
708.44 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.74 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
293.45 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.44 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
Puretech Health Plc Adr (PRTC) 最新ニュース
PureTech Health H2 Earnings Call Highlights - Yahoo Finance
PureTech Health (NASDAQ:PRTC) Posts Quarterly Earnings Results, Beats Estimates By $0.59 EPS - MarketBeat
[20-F] PureTech Health plc Files Annual Report (Foreign Issuer) | PRTC SEC FilingForm 20-F - Stock Titan
Earnings call transcript: PureTech Health’s mixed FY2025 results spark stock drop - Investing.com India
PureTech Health (PRTC) ends Nasdaq ADS listing, focuses trading on LSE - Stock Titan
PureTech to Exit Nasdaq Listing and Consolidise Trading in London - Yahoo Finance UK
PureTech Health to delist ADSs from Nasdaq, focus on LSE By Investing.com - Investing.com South Africa
PureTech Health to delist ADSs from Nasdaq, focus on LSE - Investing.com
PureTech Announces Annual Results for Year Ended December 31, 2025 - ChartMill
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange - Business Wire
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors - ChartMill
PureTech Health (PRTC) Expected to Announce Earnings on Wednesday - MarketBeat
PRTC.L Technical Analysis | Trend, Signals & Chart Patterns | PURETECH HEALTH PLC (LON:PRTC) - ChartMill
0VQ.DE Stock Price, Quote & Chart | PURETECH HEALTH PLC (FRA:0VQ) - ChartMill
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 30.8% in March - MarketBeat
Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.
PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers - ChartMill
PureTech publishes phase 2b deupirfenidone IPF trial results - Investing.com
PRTC Stock Price, Quote & Chart | PURETECH HEALTH PLCADR (NASDAQ:PRTC) - ChartMill
Short Interest in PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Rises By 140.8% - MarketBeat
Short Interest in Citizens Bancorp of Virginia, Inc. (OTCMKTS:CZBT) Grows By 141.4% - Defense World
Pacer American Energy Independence ETF (NYSEARCA:USAI) Sees Large Increase in Short Interest - Defense World
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans - ChartMill
Lansdowne Partners UK LLP Takes Position in PureTech Health PLC Sponsored ADR $PRTC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 36.2% in February - MarketBeat
PureTech Health in the FTSE landscape as technical momentum shifts - Kalkine Media
PureTech to Present at the Leerink Partners Global Healthcare Conference - ChartMill
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Update - MarketBeat
PureTech Health (NASDAQ:PRTC) Shares Up 2%Here's Why - MarketBeat
PRTC Stock Price and Chart — NASDAQ:PRTC - TradingView — Track All Markets
PureTech Health (NASDAQ:PRTC) Trading Up 5.7%Here's Why - MarketBeat
PureTech Health (NASDAQ:PRTC) Trading Up 5.7% – Here’s Why - Defense World
PureTech CEO to present at J.P. Morgan Healthcare Conference By Investing.com - Investing.com India
PureTech CEO to present at J.P. Morgan Healthcare Conference - Investing.com
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Decrease in Short Interest - Defense World
PureTech Health appoints Robert Lyne as permanent CEO By Investing.com - Investing.com UK
PureTech Health appoints Robert Lyne as permanent CEO - Investing.com
PureTech Health (NASDAQ:PRTC) Trading Down 0.7% – Time to Sell? - Defense World
PureTech Health (NASDAQ:PRTC) Trading Down 0.7%Time to Sell? - MarketBeat
PureTech provides update on AGM results following shareholder concerns - Investing.com
PureTech stock falls after FDA meeting on IPF drug - Investing.com
PureTech Health (NASDAQ:PRTC) Trading 0.4% HigherStill a Buy? - MarketBeat
PureTech Health (NASDAQ:PRTC) Stock Price Up 3.1%Time to Buy? - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 100.0% in September - MarketBeat
PureTech Health Sees Strong Market Presence in FTSE All Share - Kalkine Media
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
BioHarvest Sciences (BHST) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
PureTech launches new entity to advance IPF treatment deupirfenidone - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health announces board leadership transition - Investing.com
Puretech Health Plc Adr (PRTC) 財務データ
収益
当期純利益
現金流量
EPS
0.83%
2.04%
大文字化:
|
ボリューム (24 時間):